Stock Price
73.76
Daily Change
-0.58 -0.78%
Monthly
-4.46%
Yearly
-29.28%
Q2 Forecast
71.84

Symrise reported EUR2.08B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Avient USD 2.41B 7.06B Mar/2026
Chemours USD 1.34B 11M Mar/2026
Corteva USD 3.75B 650.92M Mar/2026
Covestro EUR 3.24B 5.46B Dec/2025
Symrise EUR 2.08B 118.33M Dec/2024
Victrex GBP 128.1M 4.2M Jun/2026